Back
Denali Therapeutics Stock Price Chart
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.94
Seasonality Move:
17.79%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.38 | Buy |
| 20-day SMA: | 26.7 | Buy |
| 50-day SMA: | 24.56 | Buy |
| 200-day SMA: | 20.65 | Buy |
| 8-day EMA: | 29.49 | Buy |
| 20-day EMA: | 27.36 | Buy |
| 50-day EMA: | 25.05 | Buy |
| 200-day EMA: | 22.29 | Buy |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.89 | Buy |
| Relative Strength Index (14 RSI): | 78.97 | Buy |
| Chaikin Money Flow: | -360034 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.61 - 28.65) | Buy |
| Bollinger Bands (100): | (19.18 - 25.48) | Buy |
Denali Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 31.08 while DNLI 8-day simple moving average is 29.38, which is a Buy signal.
- The stock price of DNLI is 31.08 while Denali Therapeutics 20-day SMA is 26.70, which makes it a Buy.
- Denali Therapeutics 50-day simple moving average is 24.56 while DNLI share price is 31.08, making it a Buy technically.
- DNLI stock price is 31.08 and Denali Therapeutics 200-day simple moving average is 20.65, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Buy
The current Denali Therapeutics [DNLI] share price is $31.08. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Denali Therapeutics Stock Info
Market Cap:
4.45B
Price in USD:
31.08
Share Volume:
672.06K
Denali Therapeutics 52-Week Range
52-Week High:
32.13
52-Week Low:
14.56
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 31.08 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is not overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 31.08 while DNLI 8-day exponential moving average is 29.49, which is a Buy signal.
- The stock price of DNLI is 31.08 while Denali Therapeutics 20-day EMA is 27.36, which makes it a Buy.
- Denali Therapeutics 50-day exponential moving average is 25.05 while DNLI share price is 31.08, making it a Buy technically.
- DNLI stock price is 31.08 and Denali Therapeutics 200-day simple moving average is 22.29, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is 1.89, suggesting Denali Therapeutics is a Buy
- Denali Therapeutics Relative Strength Index (RSI) is 78.97, which suggest Denali Therapeutics is overbought
- The Bollinger Bands (25) for Denali Therapeutics is (23.61 - 28.65), which suggest Denali Therapeutics is a Buy
- The Bollinger Bands (100) for Denali Therapeutics is (19.18 - 25.48), which suggest Denali Therapeutics is a Buy
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.